DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie – Trademark Portfolio

Entity Type: 03

DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. The owner is based in Frankfurt.

Theodor-Heuss-Allee 25

Frankfurt D-60486 , DE

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie have?

DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie has 1 U.S. trademark filed with the USPTO.

What trademark classes does DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie file in?

DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What is DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie's trademark registration success rate?

DECHEMA Gesellschaft fur Chemische Technik und Biotechnologie has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.